Related Experiment Video
Updated: Jul 31, 2026
11:10
Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
Published on: November 16, 2011
ECM gene expression and its modulation by insulin in diabetic rats
M Fukui1, T Nakamura, I Ebihara
1Department of Medicine, Juntendo University School of Medicine, Tokyo, Japan.
Diabetes
|December 1, 1992
Summary
Diabetic nephropathy involves abnormal extracellular matrix (ECM) gene expression in rat glomeruli, leading to basement membrane thickening. Insulin therapy reversed these changes, suggesting hyperglycemia drives diabetic kidney disease.
Area of Science:
- Nephrology
- Molecular Biology
- Diabetic Complications
Background:
- Diabetic nephropathy is characterized by glomerular basement membrane thickening and mesangial expansion.
- The precise molecular mechanisms driving these changes in early diabetes remain incompletely understood.
Purpose of the Study:
- To investigate the temporal changes in gene expression of key extracellular matrix (ECM) components in the glomeruli of streptozotocin (STZ)-induced diabetic rats.
- To determine the effect of insulin treatment on ECM gene expression in diabetic nephropathy.
Main Methods:
- Quantitative analysis of steady-state mRNA levels for alpha 1(IV) collagen, laminin B1/B2 chains, basement membrane HSPG, and alpha 1(I)/alpha 1(III) collagen in rat glomeruli.
- Comparison of gene expression at 4, 12, and 24 weeks post-STZ injection in diabetic rats versus control rats.
- Assessment of gene expression following 4 weeks of insulin treatment in diabetic rats.
Main Results:
- Diabetic rats showed significant age-dependent increases in mRNA for alpha 1(IV) collagen, laminin B1/B2, and alpha 1(I)/alpha 1(III) collagen before basement membrane thickening.
- HSPG mRNA levels decreased initially post-STZ but then increased with age in diabetic rats, contrasting with a decline in controls.
- Insulin treatment normalized the dysregulated ECM gene expression in diabetic glomeruli.
Conclusions:
- Abnormal regulation of ECM gene expression in glomeruli contributes to mesangial expansion and basement membrane thickening in diabetic nephropathy.
- Hyperglycemia likely plays a critical role in mediating the aberrant ECM gene expression observed in diabetic kidney disease.
- Targeting hyperglycemia or its downstream effects may be a therapeutic strategy for diabetic nephropathy.
Related Concept Videos
01:58Cell Specific Gene Expression
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
01:16Hormones Regulating Blood Glucose
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...
01:28Insulin: The Receptor and Signaling Pathways
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
01:25Insulin: Biosynthesis, Chemistry, and Preparation
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.